Zhimei Lv

807 citations
15 papers · 460 indexed · 1 hit paper · h-index 12
Topics
Renal Diseases and Glomerulopathies (4 papers)Cancer-related molecular mechanisms research (4 papers)Chronic Kidney Disease and Diabetes (3 papers)
Partner nations
China

In The Last Decade

Zhimei Lv

15 papers receiving 460 citations

Hit Papers

Mitochondrial metabolic reprogramming in diabetic kidney ...202420262025202410203040

Peers

Zhimei Lv
Comparison fields: 5 of 75
  • Molecular Biology 234
  • Nephrology 149
  • Cancer Research 73
  • Epidemiology 55
  • Surgery 46
Replace Xianglan Quan with:
Xianglan Quan South Korea
Xing Mao China
Chakradhar Velagapudi United States
Ranjan Das South Korea
Xiaoyan Hou China
Pengchao Du China
Shan Xiong China
Almut Nitsche Germany
Thor Tejada United States
Xiujin Shen China
Zhimei Lv relative to Xianglan Quan South Korea Xianglan Quan's profile →
Citations per field
00.5×3.4×
Xianglan Quan · 1×
Citations per year

Countries citing papers authored by Zhimei Lv

Since Specialization
Citations

This map shows the geographic impact of Zhimei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhimei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhimei Lv more than expected).

Fields of papers citing papers by Zhimei Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhimei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhimei Lv. The network helps show where Zhimei Lv may publish in the future.

Co-authorship network of co-authors of Zhimei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Zhimei Lv. A scholar is included among the top collaborators of Zhimei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhimei Lv. Zhimei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1
Mitochondrial metabolic reprogramming in diabetic kidney diseasebreakdown →
42
2 15
3 7
4 23
5 34
6 25
7 15
8 44
9 21
10 18
11 39
12 56
13 8
14 10
15 103

About Zhimei Lv

Zhimei Lv is a scholar working on Nephrology, Endocrine and Autonomic Systems and Cancer Research, having authored 15 papers that have together received 460 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (4 papers), Cancer-related molecular mechanisms research (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Nephrology (149 citations), Clinical Biochemistry (36 citations) and Cancer Research (73 citations). Zhimei Lv has collaborated with scholars based in China. Frequent co-authors include Rong Wang, Jiangong Lin, Qiang Wan, Mengsi Hu, Qun Wang, Yi Liu, Junhui Zhen, Junhui Zhen, Qiqi Ma and Minghua Fan. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026